Helicobacter pylori (H. pylori) Infection-Associated Anemia in the Asir Region, Saudi Arabia

Abstract

H. pylori (ubiquitous) and anemia together represent one of the growing health concerns globally. Gastroduodenal sequelae of H. pylori infection are distinguished; however, for the H. pylori infection and its implication in the development of anemia, iron has a significant health impact. We aimed to evaluate H. pylori infection-associated anemia by employing a logistic regression analysis model. A retrospective (case–control) study design-based assessment of the H. pylori associated-anemia. The study area was geo-referenced by QGIS/QuickMapServies. Descriptive and inferential statistical analyses were accomplished using the R-base–R-studio (v-4.0.2)-tidyverse. A p-value < 0.05 was the statistical significance cut-off value. A ggplot2 package was used for data representation and visualization. Mean ± SD age, Hb, MCV, ferritin, and RBC for overall study participants were measured to be 44.0 ± 13.58, 13.84 ± 2.49, 83.02 ± 8.31, 59.42 ± 68.37, and 5.14 ± 0.75, respectively. Decreased levels of Hb (infected vs. uninfected: 13.26 ± 2.92 vs. 14.42 ± 1.75, p < 0.001) ferritin (infected vs. uninfected: 48.11 ± 63.75 vs. 71.17 ± 71.14, p < 0.001), and MCV (infected vs. uninfected: 81.29 ± 9.13 vs. and 84.82 ± 6.93, p < 0.05) were measured to be associated with H. pylori infection when compared with H. pylori uninfected control group. Moreover, the magnitude (prevalence) of anemia (infected vs. uninfected: 78% vs. 21%, p < 0.001), iron deficiency anemia (IDA) (infected vs. uninfected: 63.3% vs. 36.6%, p < 0.001), and microcytic anemia (infected vs. uninfected: 71.6% vs. 46.1%, p < 0.001) were significantly different among the H. pylori-infected participants. The higher likelihood of developing anemia (AOR; 4.98, 95% CI; 3.089–8.308, p < 0.001), IDA (AOR; 3.061, 95% CI; 2.135–4.416, p < 0.001), and microcytic anemia (AOR; 3.289, 95% CI; 2.213–4.949, p < 0.001) by 398%, 206.1%, and 229%, respectively, was associated with H. pylori-infected. We recommend the regular monitoring of hematological parameters and eradication of H. pylori infection to minimize the extra-gastric health consequences of H. pylori infection.

Advancing Gastrointestinal Health: Curcumin’s Efficacy and Nanopreparations

“…The efficacy and safety of CCM in UC treatment needs to be further verified by more RCTs, although CCM may improve activity index, clinical response, and endoscopic response in UC patients, and reduce ESR and CRP, these findings require further confirmation. [55], it still affects almost half of the world's population [56]. This bacterium is highly associated with duodenal ulcers, gastric ulcers, and gastric cancer.…”

Helicobacter pylori: A Contemporary Perspective on Pathogenesis, Diagnosis and Treatment Strategies

“…H. pylori infection is quite common worldwide, with approximately 50% of the world’s population reported to be infected [ 8 ]. The prevalence, however, is observed to vary depending on the geographical conditions, people’s socioeconomic status, temperature, and the hygiene conditions in a particular region [ 9 ].…”

Evaluation of Anti-Ulcerogenic Effects of the Crude Extract and Fractions of Dialium guineense Tree Bark in Ethanol-Induced Peptic Ulcer in Albino Rats

“…Alteration of RBC parameters in ulcer patients are associated with different mechanisms; including decreased iron absorption secondary to chronic gastritis 63 , iron loss via hemorrhagic gastritis, active bleeding peptic ulcers, deficiency of iron and vitamin B 12 secondary to chronic and atrophic gastritis, which might contribute to the alteration of RBC parameters 64 . The significant (p<0.05) lower RBC count in the negative control could be as a result of increased bleeding thus, indicative of hemorrhagic gastritis.…”